{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:02:02Z","timestamp":1783728122151,"version":"3.55.0"},"reference-count":87,"publisher":"Aging and Disease","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2021]]},"DOI":"10.14336\/ad.2021.0406","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:22:08Z","timestamp":1630509728000},"page":"1389","source":"Crossref","is-referenced-by-count":29,"title":["Astrocytes & Astrocyte derived Extracellular Vesicles in Morphine Induced Amyloidopathy: Implications for Cognitive Deficits in Opiate Abusers"],"prefix":"10.14336","volume":"12","author":[{"given":"Susmita","family":"Sil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya T","family":"Chemparathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest T","family":"Chivero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Buch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2021.0406-1","unstructured":"Stefano GB, Ptacek R, Kuzelova H, Kream RM (2012). Endogenous morphine: up-to-date review 2011. Folia Biol (Praha), 58:49-56."},{"key":"key-10.14336\/AD.2021.0406-2","doi-asserted-by":"crossref","unstructured":"Kent CD, Stephens LS, Posner KL, Domino KB (2017). What Adverse Events and Injuries Are Cited in Anesthesia Malpractice Claims for Nonspine Orthopaedic Surgery? Clin Orthop Relat Res, 475:2941-2951.","DOI":"10.1007\/s11999-017-5303-z"},{"key":"key-10.14336\/AD.2021.0406-3","doi-asserted-by":"crossref","unstructured":"Friedman H, Eisenstein TK (2004). Neurological basis of drug dependence and its effects on the immune system. J Neuroimmunol, 147:106-108.","DOI":"10.1016\/j.jneuroim.2003.10.022"},{"key":"key-10.14336\/AD.2021.0406-4","doi-asserted-by":"crossref","unstructured":"Roy S, Wang J, Kelschenbach J, Koodie L, Martin J (2006). Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol, 1:77-89.","DOI":"10.1007\/s11481-005-9009-8"},{"key":"key-10.14336\/AD.2021.0406-5","doi-asserted-by":"crossref","unstructured":"Roy S, Barke RA, Loh HH (1998). MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res, 61:190-194.","DOI":"10.1016\/S0169-328X(98)00212-5"},{"key":"key-10.14336\/AD.2021.0406-6","doi-asserted-by":"crossref","unstructured":"Roy S, Ninkovic J, Banerjee S, Charboneau RG, Das S, Dutta R, et al. (2011). Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol, 6:442-465.","DOI":"10.1007\/s11481-011-9292-5"},{"key":"key-10.14336\/AD.2021.0406-7","doi-asserted-by":"crossref","unstructured":"Chau DL, Walker V, Pai L, Cho LM (2008). Opiates and elderly: use and side effects. Clin Interv Aging, 3:273-278.","DOI":"10.2147\/CIA.S1847"},{"key":"key-10.14336\/AD.2021.0406-8","doi-asserted-by":"crossref","unstructured":"Roy S, Chapin RB, Cain KJ, Charboneau RG, Ramakrishnan S, Barke RA (1997). Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cell Immunol, 179:1-9.","DOI":"10.1006\/cimm.1997.1147"},{"key":"key-10.14336\/AD.2021.0406-9","doi-asserted-by":"crossref","unstructured":"Roy S, Cain KJ, Charboneau RG, Barke RA (1998). Morphine accelerates the progression of sepsis in an experimental sepsis model. Adv Exp Med Biol, 437:21-31.","DOI":"10.1007\/978-1-4615-5347-2_3"},{"key":"key-10.14336\/AD.2021.0406-10","doi-asserted-by":"crossref","unstructured":"Dinda A, Gitman M, Singhal PC (2005). Immunomodulatory effect of morphine: therapeutic implications. Expert Opin Drug Saf, 4:669-675.","DOI":"10.1517\/14740338.4.4.669"},{"key":"key-10.14336\/AD.2021.0406-11","doi-asserted-by":"crossref","unstructured":"Sullivan MD (2018). Depression Effects on Long-term Prescription Opioid Use, Abuse, and Addiction. Clin J Pain, 34:878-884.","DOI":"10.1097\/AJP.0000000000000603"},{"key":"key-10.14336\/AD.2021.0406-12","doi-asserted-by":"crossref","unstructured":"Terrett G, McLennan SN, Henry JD, Biernacki K, Mercuri K, Curran HV, et al. (2014). Prospective memory impairment in long-term opiate users. Psychopharmacology (Berl), 231:2623-2632.","DOI":"10.1007\/s00213-014-3432-6"},{"key":"key-10.14336\/AD.2021.0406-13","doi-asserted-by":"crossref","unstructured":"Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM (2012). Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med, 172:425-430.","DOI":"10.1001\/archinternmed.2011.1827"},{"key":"key-10.14336\/AD.2021.0406-14","doi-asserted-by":"crossref","unstructured":"Lawlor PG (2002). The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal. Cancer, 94:1836-1853.","DOI":"10.1002\/cncr.10389"},{"key":"key-10.14336\/AD.2021.0406-15","doi-asserted-by":"crossref","unstructured":"Kamboj SK, Tookman A, Jones L, Curran VH (2005). The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain, 117:388-395.","DOI":"10.1016\/j.pain.2005.06.022"},{"key":"key-10.14336\/AD.2021.0406-16","doi-asserted-by":"crossref","unstructured":"Sjogren P, Christrup LL, Petersen MA, Hojsted J (2005). Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. Eur J Pain, 9:453-462.","DOI":"10.1016\/j.ejpain.2004.10.005"},{"key":"key-10.14336\/AD.2021.0406-17","doi-asserted-by":"crossref","unstructured":"Kinzel S, Weber MS (2016). B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence. CNS Drugs, 30:1137-1148.","DOI":"10.1007\/s40263-016-0396-6"},{"key":"key-10.14336\/AD.2021.0406-18","doi-asserted-by":"crossref","unstructured":"Kapogiannis D, Mattson MP (2011). Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol, 10:187-198.","DOI":"10.1016\/S1474-4422(10)70277-5"},{"key":"key-10.14336\/AD.2021.0406-19","doi-asserted-by":"crossref","unstructured":"Querfurth HW, LaFerla FM (2010). Alzheimer's disease. N Engl J Med, 362:329-344.","DOI":"10.1056\/NEJMra0909142"},{"key":"key-10.14336\/AD.2021.0406-20","doi-asserted-by":"crossref","unstructured":"Multhaup G (2006). Amyloid precursor protein and BACE function as oligomers. Neurodegener Dis, 3:270-274.","DOI":"10.1159\/000095266"},{"key":"key-10.14336\/AD.2021.0406-21","doi-asserted-by":"crossref","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. (1999). Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 286:735-741.","DOI":"10.1126\/science.286.5440.735"},{"key":"key-10.14336\/AD.2021.0406-22","doi-asserted-by":"crossref","unstructured":"Vassar R (2002). Beta-secretase (BACE) as a drug target for Alzheimer's disease. Adv Drug Deliv Rev, 54:1589-1602.","DOI":"10.1016\/S0169-409X(02)00157-6"},{"key":"key-10.14336\/AD.2021.0406-23","doi-asserted-by":"crossref","unstructured":"Roggo S (2002). Inhibition of BACE, a promising approach to Alzheimer's disease therapy. Curr Top Med Chem, 2:359-370.","DOI":"10.2174\/1568026024607490"},{"key":"key-10.14336\/AD.2021.0406-24","doi-asserted-by":"crossref","unstructured":"Anthony IC, Norrby KE, Dingwall T, Carnie FW, Millar T, Arango JC, et al. (2010). Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Brain, 133:3685-3698.","DOI":"10.1093\/brain\/awq263"},{"key":"key-10.14336\/AD.2021.0406-25","doi-asserted-by":"crossref","unstructured":"Ramage SN, Anthony IC, Carnie FW, Busuttil A, Robertson R, Bell JE (2005). Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers. Neuropathol Appl Neurobiol, 31:439-448.","DOI":"10.1111\/j.1365-2990.2005.00670.x"},{"key":"key-10.14336\/AD.2021.0406-26","doi-asserted-by":"crossref","unstructured":"Sil S, Hu G, Liao K, Niu F, Callen S, Periyasamy P, et al. (2020). HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1alpha\/lncRNA BACE1-AS axis. PLoS Biol, 18:e3000660.","DOI":"10.1371\/journal.pbio.3000660"},{"key":"key-10.14336\/AD.2021.0406-27","doi-asserted-by":"crossref","unstructured":"Cai Y, Yang L, Hu G, Chen X, Niu F, Yuan L, et al. (2016). Regulation of morphine-induced synaptic alterations: Role of oxidative stress, ER stress, and autophagy. J Cell Biol, 215:245-258.","DOI":"10.1083\/jcb.201605065"},{"key":"key-10.14336\/AD.2021.0406-28","doi-asserted-by":"crossref","unstructured":"Gonzalez-Reyes RE, Nava-Mesa MO, Vargas-Sanchez K, Ariza-Salamanca D, Mora-Munoz L (2017). Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective. Front Mol Neurosci, 10:427.","DOI":"10.3389\/fnmol.2017.00427"},{"key":"key-10.14336\/AD.2021.0406-29","doi-asserted-by":"crossref","unstructured":"Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W (2011). Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis, 2:e167.","DOI":"10.1038\/cddis.2011.50"},{"key":"key-10.14336\/AD.2021.0406-30","doi-asserted-by":"crossref","unstructured":"Margolis L, Sadovsky Y (2019). The biology of extracellular vesicles: The known unknowns. PLoS Biol, 17:e3000363.","DOI":"10.1371\/journal.pbio.3000363"},{"key":"key-10.14336\/AD.2021.0406-31","doi-asserted-by":"crossref","unstructured":"Gupta A, Pulliam L (2014). Exosomes as mediators of neuroinflammation. J Neuroinflammation, 11:68.","DOI":"10.1186\/1742-2094-11-68"},{"key":"key-10.14336\/AD.2021.0406-32","doi-asserted-by":"crossref","unstructured":"Thery C, Ostrowski M, Segura E (2009). Membrane vesicles as conveyors of immune responses. Nat Rev Immunol, 9:581-593.","DOI":"10.1038\/nri2567"},{"key":"key-10.14336\/AD.2021.0406-33","doi-asserted-by":"crossref","unstructured":"Cocucci E, Racchetti G, Meldolesi J (2009). Shedding microvesicles: artefacts no more. Trends Cell Biol, 19:43-51.","DOI":"10.1016\/j.tcb.2008.11.003"},{"key":"key-10.14336\/AD.2021.0406-34","doi-asserted-by":"crossref","unstructured":"Piccin A, Murphy WG, Smith OP (2007). Circulating microparticles: pathophysiology and clinical implications. Blood Rev, 21:157-171.","DOI":"10.1016\/j.blre.2006.09.001"},{"key":"key-10.14336\/AD.2021.0406-35","unstructured":"Shi Q, Hodara V, Meng Q, Voruganti VS, Rice K, Michalek JE, et al. (2014). Early endothelial damage detected by circulating particles in baboons fed a diet high in simple carbohydrates in conjunction with saturated or unsaturated fat. Am J Cardiovasc Dis, 4:123-132."},{"key":"key-10.14336\/AD.2021.0406-36","doi-asserted-by":"crossref","unstructured":"Taylor DD, Gercel-Taylor C (2011). Exosomes\/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol, 33:441-454.","DOI":"10.1007\/s00281-010-0234-8"},{"key":"key-10.14336\/AD.2021.0406-37","doi-asserted-by":"crossref","unstructured":"Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH (2009). Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer, 10:42-46.","DOI":"10.3816\/CLC.2009.n.006"},{"key":"key-10.14336\/AD.2021.0406-38","doi-asserted-by":"crossref","unstructured":"Narayanan A, Iordanskiy S, Das R, Van Duyne R, Santos S, Jaworski E, et al. (2013). Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA. J Biol Chem, 288:20014-20033.","DOI":"10.1074\/jbc.M112.438895"},{"key":"key-10.14336\/AD.2021.0406-39","doi-asserted-by":"crossref","unstructured":"Sardar Sinha M, Ansell-Schultz A, Civitelli L, Hildesjo C, Larsson M, Lannfelt L, et al. (2018). Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol, 136:41-56.","DOI":"10.1007\/s00401-018-1868-1"},{"key":"key-10.14336\/AD.2021.0406-40","doi-asserted-by":"crossref","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, et al. (2014). Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol, 128:639-650.","DOI":"10.1007\/s00401-014-1314-y"},{"key":"key-10.14336\/AD.2021.0406-41","doi-asserted-by":"crossref","unstructured":"Roy J, Saucier D, O'Connell C, Morin PJ (2019). Extracellular vesicles and their diagnostic potential in amyotrophic lateral sclerosis. Clin Chim Acta, 497:27-34.","DOI":"10.1016\/j.cca.2019.07.012"},{"key":"key-10.14336\/AD.2021.0406-42","doi-asserted-by":"crossref","unstructured":"Sampey GC, Saifuddin M, Schwab A, Barclay R, Punya S, Chung MC, et al. (2016). Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA. J Biol Chem, 291:1251-1266.","DOI":"10.1074\/jbc.M115.662171"},{"key":"key-10.14336\/AD.2021.0406-43","doi-asserted-by":"crossref","unstructured":"Hu G, Liao K, Niu F, Yang L, Dallon BW, Callen S, et al. (2018). Astrocyte EV-Induced lincRNA-Cox2 Regulates Microglial Phagocytosis: Implications for Morphine-Mediated Neurodegeneration. Mol Ther Nucleic Acids, 13:450-463.","DOI":"10.1016\/j.omtn.2018.09.019"},{"key":"key-10.14336\/AD.2021.0406-44","doi-asserted-by":"crossref","unstructured":"Yang L, Niu F, Yao H, Liao K, Chen X, Kook Y, et al. (2018). Exosomal miR-9 Released from HIV Tat Stimulated Astrocytes Mediates Microglial Migration. J Neuroimmune Pharmacol, 13:330-344.","DOI":"10.1007\/s11481-018-9779-4"},{"key":"key-10.14336\/AD.2021.0406-45","doi-asserted-by":"crossref","unstructured":"Yuyama K, Igarashi Y (2017). Exosomes as Carriers of Alzheimer's Amyloid-ss. Front Neurosci, 11:229.","DOI":"10.3389\/fnins.2017.00229"},{"key":"key-10.14336\/AD.2021.0406-46","doi-asserted-by":"crossref","unstructured":"Beretta C, Nikitidou E, Streubel-Gallasch L, Ingelsson M, Sehlin D, Erlandsson A (2020). Extracellular vesicles from amyloid-beta exposed cell cultures induce severe dysfunction in cortical neurons. Sci Rep, 10:19656.","DOI":"10.1038\/s41598-020-72355-2"},{"key":"key-10.14336\/AD.2021.0406-47","doi-asserted-by":"crossref","unstructured":"Eitan E, Hutchison ER, Marosi K, Comotto J, Mustapic M, Nigam SM, et al. (2016). Extracellular Vesicle-Associated Abeta Mediates Trans-Neuronal Bioenergetic and Ca(2+)-Handling Deficits in Alzheimer's Disease Models. NPJ Aging Mech Dis, 2.","DOI":"10.1038\/npjamd.2016.19"},{"key":"key-10.14336\/AD.2021.0406-48","doi-asserted-by":"crossref","unstructured":"Lee S, Mankhong S, Kang JH (2019). Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges. Int J Mol Sci, 20.","DOI":"10.3390\/ijms20071728"},{"key":"key-10.14336\/AD.2021.0406-49","doi-asserted-by":"crossref","unstructured":"Watson LS, Hamlett ED, Stone TD, Sims-Robinson C (2019). Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer's disease. Mol Neurodegener, 14:22.","DOI":"10.1186\/s13024-019-0317-5"},{"key":"key-10.14336\/AD.2021.0406-50","doi-asserted-by":"crossref","unstructured":"Sil S, Periyasamy P, Guo ML, Callen S, Buch S (2018). Morphine-Mediated Brain Region-Specific Astrocytosis Involves the ER Stress-Autophagy Axis. Mol Neurobiol, 55:6713-6733.","DOI":"10.1007\/s12035-018-0878-2"},{"key":"key-10.14336\/AD.2021.0406-51","doi-asserted-by":"crossref","unstructured":"Periyasamy P, Thangaraj A, Guo ML, Hu G, Callen S, Buch S (2018). Epigenetic Promoter DNA Methylation of miR-124 Promotes HIV-1 Tat-Mediated Microglial Activation via MECP2-STAT3 Axis. J Neurosci, 38:5367-5383.","DOI":"10.1523\/JNEUROSCI.3474-17.2018"},{"key":"key-10.14336\/AD.2021.0406-52","doi-asserted-by":"crossref","unstructured":"Goto Y, Zeng L, Yeom CJ, Zhu Y, Morinibu A, Shinomiya K, et al. (2015). UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1alpha. Nat Commun, 6:6153.","DOI":"10.1038\/ncomms7153"},{"key":"key-10.14336\/AD.2021.0406-53","doi-asserted-by":"crossref","unstructured":"Zhang Q, Higginbotham JN, Jeppesen DK, Yang YP, Li W, McKinley ET, et al. (2019). Transfer of Functional Cargo in Exomeres. Cell Rep, 27:940-954 e946.","DOI":"10.1016\/j.celrep.2019.01.009"},{"key":"key-10.14336\/AD.2021.0406-54","doi-asserted-by":"crossref","unstructured":"Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, et al. (2011). Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine, 7:780-788.","DOI":"10.1016\/j.nano.2011.04.003"},{"key":"key-10.14336\/AD.2021.0406-55","doi-asserted-by":"crossref","unstructured":"Hurwitz SN, Sun L, Cole KY, Ford CR 3rd, Olcese JM, Meckes DG Jr. (2018). An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer's disease. J Neurosci Methods, 307:210-220.","DOI":"10.1016\/j.jneumeth.2018.05.022"},{"key":"key-10.14336\/AD.2021.0406-56","doi-asserted-by":"crossref","unstructured":"Lyubchenko YL, Shlyakhtenko LS, Ando T (2011). Imaging of nucleic acids with atomic force microscopy. Methods, 54:274-283.","DOI":"10.1016\/j.ymeth.2011.02.001"},{"key":"key-10.14336\/AD.2021.0406-57","doi-asserted-by":"crossref","unstructured":"Han J, Li L, Zhang Z, Xiao Y, Lin J, Zheng L, et al. (2007). Platelet-derived growth factor C plays a role in the branchial arch malformations induced by retinoic acid. Birth Defects Res A Clin Mol Teratol, 79:221-230.","DOI":"10.1002\/bdra.20329"},{"key":"key-10.14336\/AD.2021.0406-58","doi-asserted-by":"crossref","unstructured":"Pare EM, Monforte JR, Thibert RJ (1984). Morphine concentrations in brain tissue from heroin-associated deaths. J Anal Toxicol, 8:213-216.","DOI":"10.1093\/jat\/8.5.213"},{"key":"key-10.14336\/AD.2021.0406-59","doi-asserted-by":"crossref","unstructured":"Liao K, Niu F, Hu G, Yang L, Dallon B, Villarreal D, et al. (2020). Morphine-mediated release of miR-138 in astrocyte-derived extracellular vesicles promotes microglial activation. J Extracell Vesicles, 10:e12027.","DOI":"10.1002\/jev2.12027"},{"key":"key-10.14336\/AD.2021.0406-60","doi-asserted-by":"crossref","unstructured":"Hu G, Gong AY, Roth AL, Huang BQ, Ward HD, Zhu G, et al. (2013). Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathog, 9:e1003261.","DOI":"10.1371\/journal.ppat.1003261"},{"key":"key-10.14336\/AD.2021.0406-61","doi-asserted-by":"crossref","unstructured":"Hu G, Yao H, Chaudhuri AD, Duan M, Yelamanchili SV, Wen H, et al. (2012). Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction. Cell Death Dis, 3:e381.","DOI":"10.1038\/cddis.2012.114"},{"key":"key-10.14336\/AD.2021.0406-62","doi-asserted-by":"crossref","unstructured":"Kalman J, Bjelik A, Hugyecz M, Timar J, Gyarmati Z, Zana M, et al. (2007). 3,4-Methylenedioxymethamphetamine (MDMA), but not morphine, alters APP processing in the rat brain. Int J Neuropsychopharmacol, 10:183-190.","DOI":"10.1017\/S146114570600650X"},{"key":"key-10.14336\/AD.2021.0406-63","doi-asserted-by":"crossref","unstructured":"Bryant CD, Roberts KW, Byun JS, Fanselow MS, Evans CJ (2006). Morphine analgesic tolerance in 129P3\/J and 129S6\/SvEv mice. Pharmacol Biochem Behav, 85:769-779.","DOI":"10.1016\/j.pbb.2006.11.012"},{"key":"key-10.14336\/AD.2021.0406-64","doi-asserted-by":"crossref","unstructured":"Volterra A, Meldolesi J (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci, 6:626-640.","DOI":"10.1038\/nrn1722"},{"key":"key-10.14336\/AD.2021.0406-65","doi-asserted-by":"crossref","unstructured":"Colomar A, Robitaille R (2004). Glial modulation of synaptic transmission at the neuromuscular junction. Glia, 47:284-289.","DOI":"10.1002\/glia.20086"},{"key":"key-10.14336\/AD.2021.0406-66","doi-asserted-by":"crossref","unstructured":"Bachoo RM, Kim RS, Ligon KL, Maher EA, Brennan C, Billings N, et al. (2004). Molecular diversity of astrocytes with implications for neurological disorders. Proc Natl Acad Sci U S A, 101:8384-8389.","DOI":"10.1073\/pnas.0402140101"},{"key":"key-10.14336\/AD.2021.0406-67","doi-asserted-by":"crossref","unstructured":"Vasile F, Dossi E, Rouach N (2017). Human astrocytes: structure and functions in the healthy brain. Brain Struct Funct, 222:2017-2029.","DOI":"10.1007\/s00429-017-1383-5"},{"key":"key-10.14336\/AD.2021.0406-68","doi-asserted-by":"crossref","unstructured":"Foerde K, Shohamy D (2011). The role of the basal ganglia in learning and memory: insight from Parkinson's disease. Neurobiol Learn Mem, 96:624-636.","DOI":"10.1016\/j.nlm.2011.08.006"},{"key":"key-10.14336\/AD.2021.0406-69","doi-asserted-by":"crossref","unstructured":"Elhalal A, Davelaar EJ, Usher M (2014). The role of the frontal cortex in memory: an investigation of the Von Restorff effect. Front Hum Neurosci, 8:410.","DOI":"10.3389\/fnhum.2014.00410"},{"key":"key-10.14336\/AD.2021.0406-70","doi-asserted-by":"crossref","unstructured":"Gremel CM, Lovinger DM (2017). Associative and sensorimotor cortico-basal ganglia circuit roles in effects of abused drugs. Genes Brain Behav, 16:71-85.","DOI":"10.1111\/gbb.12309"},{"key":"key-10.14336\/AD.2021.0406-71","doi-asserted-by":"crossref","unstructured":"Schmidt A, Denier N, Magon S, Radue EW, Huber CG, Riecher-Rossler A, et al. (2015). Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution. Transl Psychiatry, 5:e533.","DOI":"10.1038\/tp.2015.28"},{"key":"key-10.14336\/AD.2021.0406-72","doi-asserted-by":"crossref","unstructured":"Baldo BA (2016). Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis. Trends Neurosci, 39:366-377.","DOI":"10.1016\/j.tins.2016.03.004"},{"key":"key-10.14336\/AD.2021.0406-73","doi-asserted-by":"crossref","unstructured":"Saido TC, Yokota M, Maruyama K, Yamao-Harigaya W, Tani E, Ihara Y, et al. (1994). Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. J Biol Chem, 269:15253-15257.","DOI":"10.1016\/S0021-9258(17)36599-7"},{"key":"key-10.14336\/AD.2021.0406-74","doi-asserted-by":"crossref","unstructured":"Reijmer YD, van Veluw SJ, Greenberg SM (2016). Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab, 36:40-54.","DOI":"10.1038\/jcbfm.2015.88"},{"key":"key-10.14336\/AD.2021.0406-75","doi-asserted-by":"crossref","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, et al. (2016). Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-beta pathology. Brain, 139:1265-1281.","DOI":"10.1093\/brain\/aww016"},{"key":"key-10.14336\/AD.2021.0406-76","doi-asserted-by":"crossref","unstructured":"Koodie L, Ramakrishnan S, Roy S (2010). Morphine suppresses tumor angiogenesis through a HIF-1alpha\/p38MAPK pathway. Am J Pathol, 177:984-997.","DOI":"10.2353\/ajpath.2010.090621"},{"key":"key-10.14336\/AD.2021.0406-77","doi-asserted-by":"crossref","unstructured":"Roy S, Balasubramanian S, Wang J, Chandrashekhar Y, Charboneau R, Barke R (2003). Morphine inhibits VEGF expression in myocardial ischemia. Surgery, 134:336-344.","DOI":"10.1067\/msy.2003.247"},{"key":"key-10.14336\/AD.2021.0406-78","doi-asserted-by":"crossref","unstructured":"Minter MR, Taylor JM, Crack PJ (2016). The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease. J Neurochem, 136:457-474.","DOI":"10.1111\/jnc.13411"},{"key":"key-10.14336\/AD.2021.0406-79","doi-asserted-by":"crossref","unstructured":"Cisternas P, Taylor X, Lasagna-Reeves CA (2019). The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy. Int J Mol Sci, 20.","DOI":"10.3390\/ijms20246319"},{"key":"key-10.14336\/AD.2021.0406-80","doi-asserted-by":"crossref","unstructured":"Welikovitch LA, Do Carmo S, Magloczky Z, Malcolm JC, Loke J, Klein WL, et al. (2020). Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain. Proc Natl Acad Sci U S A, 117:6844-6854.","DOI":"10.1073\/pnas.1914593117"},{"key":"key-10.14336\/AD.2021.0406-81","doi-asserted-by":"crossref","unstructured":"Kalra H, Drummen GP, Mathivanan S (2016). Focus on Extracellular Vesicles: Introducing the Next Small Big Thing. Int J Mol Sci, 17:170.","DOI":"10.3390\/ijms17020170"},{"key":"key-10.14336\/AD.2021.0406-82","doi-asserted-by":"crossref","unstructured":"Sofroniew MV, Vinters HV (2010). Astrocytes: biology and pathology. Acta Neuropathol, 119:7-35.","DOI":"10.1007\/s00401-009-0619-8"},{"key":"key-10.14336\/AD.2021.0406-83","unstructured":"Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, et al. (2015). Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles, 4:27066."},{"key":"key-10.14336\/AD.2021.0406-84","doi-asserted-by":"crossref","unstructured":"van den Boorn JG, Schlee M, Coch C, Hartmann G (2011). SiRNA delivery with exosome nanoparticles. Nat Biotechnol, 29:325-326.","DOI":"10.1038\/nbt.1830"},{"key":"key-10.14336\/AD.2021.0406-85","doi-asserted-by":"crossref","unstructured":"Badhwar A, Haqqani AS (2020). Biomarker potential of brain-secreted extracellular vesicles in blood in Alzheimer's disease. Alzheimers Dement (Amst), 12:e12001.","DOI":"10.1002\/dad2.12001"},{"key":"key-10.14336\/AD.2021.0406-86","doi-asserted-by":"crossref","unstructured":"Huttunen HJ, Puglielli L, Ellis BC, MacKenzie Ingano LA, Kovacs DM (2009). Novel N-terminal cleavage of APP precludes Abeta generation in ACAT-defective AC29 cells. J Mol Neurosci, 37:6-15.","DOI":"10.1007\/s12031-008-9088-0"},{"key":"key-10.14336\/AD.2021.0406-87","doi-asserted-by":"crossref","unstructured":"Zhang W, Zhou X, Yao Q, Liu Y, Zhang H, Dong Z (2017). HIF-1-mediated production of exosomes during hypoxia is protective in renal tubular cells. Am J Physiol Renal Physiol, 313:F906-F913.","DOI":"10.1152\/ajprenal.00178.2017"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/ad-0-0-0-2104141536-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:27:28Z","timestamp":1630510048000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2021.0406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2021.0406","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}